Dual-listed drug maker AFT Pharmaceuticals board answered shareholders questions on the burgeoning medical cannabis market, Chinese markets and the impacts of Covid-19 at the company’s annual general meeting, held virtually this morning.
Chair David Flacks maintained the impact of Covid was
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
